Snowball logo
logo
AKRO

Akero Therapeutics, Inc

AKRO NASDAQ
$54.65$0.00  (0%)

Frequently asked questions

What sector does Akero Therapeutics, Inc (AKRO) operate in?

Akero Therapeutics, Inc belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Akero Therapeutics, Inc (AKRO) current stock price?

As of the latest data, Akero Therapeutics, Inc stock price is $54.65, with a previous close of $54.65.

What is Akero Therapeutics, Inc (AKRO) current market capitalization?

Akero Therapeutics, Inc market cap is approximately 4.50 billion.

What is Akero Therapeutics, Inc (AKRO) Earnings Per Share (EPS)?

The trailing EPS is -$3.75, and the forward EPS is -$4.22.

What is Akero Therapeutics, Inc (AKRO) EBITDA?

Akero Therapeutics, Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -80.47 million.

Does Akero Therapeutics, Inc (AKRO) pay dividends?

No. Akero Therapeutics, Inc does not pay a dividend.

When is Akero Therapeutics, Inc (AKRO) next earnings report?

Akero Therapeutics, Inc is expected to release its next earnings report on December 31, 2025.

What is Akero Therapeutics, Inc (AKRO) beta (volatility) score?

Akero Therapeutics, Inc has a beta of -0.404, indicating lower volatility than the overall market.